Source: International Congress 2017 – How can microbiology and translational research help physicians?
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Sergio (Bresso, MI, Italy). Synergistic activity of N-acetylcysteine and colistin against Stenotrophomonas maltophilia. 3317

Member's Comments

No comment yet.

Related content which might interest you: Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter Baumannii grown in biofilms Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Activity of N-acetylcysteine in combination with colistin against a collection of colistin resistant Acinetobacter baumannii clinical isolates Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 Bronchiectasis and Stenotrophomonas maltophilia Source: Eur Respir J 2003; 22: Suppl. 45, 515s Year: 2003 Inhaled colistin on Acinetobacter baumannii treatment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Effects of subinhibitory concentrations of antibiotics on the biofilm formation of pseudomonas aeruginosa Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006 CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro Source: Eur Respir J 2003; 21: 401-406 Year: 2003 Therapeutic efficacy of macrolides, minocycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults. Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Resistance of Streptococcus pneumoniae to penicillin, azitromycin, ciprofloxacyn and ceftriaxon Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection Source: Eur Respir J 2005; 25: 911-914 Year: 2005 Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Macrolide resistance in Pseudomonas aeruginosa: implications for practice Source: Eur Respir J, 49 (5) 1700689; 10.1183/13993003.00689-2017 Year: 2017